Shari A Pilon-Thomas (Shari Pilon-Thomas)

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 12

Top Topics

Combination Therapy

Diffusion Weighted Imaging

Peripheral Blood

Top Venues

Contrast media & molecular imaging

Molecular cancer therapeutics

Clinical cancer research : an official journal of the American Association for Cancer Research

This page only lists publications with an associated author ORCID identifier.

Publications

Joseph Markowitz, Michael Shamblott, Andrew S Brohl, Amod A Sarnaik, Zeynep Eroglu, Nikhil I Khushalani, Christopher W Dukes, Alejandra Chamizo, Marina Bastawrous, Edward T Garcia, Ashraf Dehlawi, Pei-Ling Chen, Deanryan B De Aquino, Vernon K Sondak, Ahmad A Tarhini, Youngchul Kim, Patricia Lawman, Shari A Pilon-Thomas
First-in-Human Stage III/IV Melanoma Clinical Trial of Immune Priming Agent IFx-Hu2.0. Molecular cancer therapeutics 23 (8) (2024)
Joseph Markowitz, Michael Shamblott, Andrew S Brohl, Amod A Sarnaik, Zeynep Eroglu, Nikhil I Khushalani, Christopher W Dukes, Alejandra Chamizo, Marina Bastawrous, Edward T Garcia, Ashraf Dehlawi, Pei-Ling Chen, Deanryan B De Aquino, Vernon K Sondak, Ahmad A Tarhini, Youngchul Kim, Patricia Lawman, Shari A Pilon-Thomas
First-in-Human Stage III/IV Melanoma Clinical Trial of Immune Priming Agent IFx-Hu2.0. Molecular cancer therapeutics 23 (8) (2024)
Joseph Markowitz, Michael Shamblott, Andrew S Brohl, Amod A Sarnaik, Zeynep Eroglu, Nikhil I Khushalani, Christopher W Dukes, Alejandra Chamizo, Marina Bastawrous, Edward T Garcia, Ashraf Dehlawi, Pei-Ling Chen, Deanryan B De Aquino, Vernon K Sondak, Ahmad A Tarhini, Youngchul Kim, Patricia Lawman, Shari A Pilon-Thomas
First-in-human stage III/IV melanoma clinical trial of immune priming agent IFx-Hu2.0. Molecular cancer therapeutics (2024)
Joseph Markowitz, Michael Shamblott, Andrew S Brohl, Amod A Sarnaik, Zeynep Eroglu, Nikhil I Khushalani, Christopher W Dukes, Alejandra Chamizo, Marina Bastawrous, Edward T Garcia, Ashraf Dehlawi, Pei-Ling Chen, Deanryan B De Aquino, Vernon K Sondak, Ahmad A Tarhini, Youngchul Kim, Patricia Lawman, Shari A Pilon-Thomas
First-in-Human Stage III/IV Melanoma Clinical Trial of Immune Priming Agent IFx-Hu2.0. Molecular cancer therapeutics 23 (8) (2024)
Bruna Victorasso Jardim-Perassi, Pietro Irrera, Justin Y C Lau, Mikalai M Budzevich, Christopher J Whelan, Dominique Abrahams, Epifanio Ruiz, Arig Ibrahim-Hashim, Sultan Damgaci Erturk, Dario Livio Longo, Shari A Pilon-Thomas, Robert James Gillies
Intraperitoneal Delivery of Iopamidol to Assess Extracellular pH of Orthotopic Pancreatic Tumor Model by CEST-MRI. Contrast media & molecular imaging 2023 (2023)
Bruna Victorasso Jardim-Perassi, Pietro Irrera, Justin Y C Lau, Mikalai M Budzevich, Christopher J Whelan, Dominique Abrahams, Epifanio Ruiz, Arig Ibrahim-Hashim, Sultan Damgaci Erturk, Dario Livio Longo, Shari A Pilon-Thomas, Robert James Gillies
Intraperitoneal Delivery of Iopamidol to Assess Extracellular pH of Orthotopic Pancreatic Tumor Model by CEST-MRI. Contrast media & molecular imaging 2023 (2023)
Bruna Victorasso Jardim-Perassi, Pietro Irrera, Justin Y C Lau, Mikalai M Budzevich, Christopher J Whelan, Dominique Abrahams, Epifanio Ruiz, Arig Ibrahim-Hashim, Sultan Damgaci Erturk, Dario Livio Longo, Shari A Pilon-Thomas, Robert James Gillies
Intraperitoneal Delivery of Iopamidol to Assess Extracellular pH of Orthotopic Pancreatic Tumor Model by CEST-MRI. Contrast media & molecular imaging 2023 (2023)
Bruna Victorasso Jardim-Perassi, Pietro Irrera, Justin Y C Lau, Mikalai M Budzevich, Christopher J Whelan, Dominique Abrahams, Epifanio Ruiz, Arig Ibrahim-Hashim, Sultan Damgaci Erturk, Dario Livio Longo, Shari A Pilon-Thomas, Robert James Gillies
Intraperitoneal Delivery of Iopamidol to Assess Extracellular pH of Orthotopic Pancreatic Tumor Model by CEST-MRI. Contrast media & molecular imaging 2023 (2023)
Caitlin A Creasy, Yuzhong Jeff Meng, Marie-Andrée Forget, Tatiana Karpinets, Katarzyna Tomczak, Chip Stewart, Carlos A Torres-Cabala, Shari A Pilon-Thomas, Amod A Sarnaik, James J Mule, Levi Garraway, Matias A Bustos, Jianhua Zhang, Sapna Pradyuman Patel, Adi Diab, Isabella C Glitza Oliva, Cassian Yee, Hussein Tawbi, Michael K Wong, Jennifer Leigh McQuade, Dave S B Hoon, Michael A Davies, Patrick Hwu, Rodabe N Amaria, Cara L Haymaker, Rameen Beroukhim, Chantale Bernatchez
Genomic Correlates of Outcome in Tumor-Infiltrating Lymphocyte Therapy for Metastatic Melanoma. Clinical cancer research : an official journal of the American Association for Cancer Research 28 (9) (2022)
MacLean S Hall, John E Mullinax, Cheryl A Cox, Amy M Hall, Matthew S Beatty, Jamie Blauvelt, Patrick Innamarato, Luz E Nagle, Holly Branthoover, Doris Wiener, Benjamin I Schachner, Alberto J Martinez, Allison D Richards, Carolyn J Rich, Marjorie Colón Colón, Michael J Schell, Jamie K Teer, Nikhil I Khushalani, Jeffrey S Weber, James J Mule, Vernon K Sondak, Shari A Pilon-Thomas, Amod A Sarnaik
Combination Nivolumab, CD137 Agonism, and Adoptive Cell Therapy with Tumor-Infiltrating Lymphocytes for Patients with Metastatic Melanoma. Clinical cancer research : an official journal of the American Association for Cancer Research (2022)
Rebecca A Bekker, Mohammad U Zahid, Jennifer M Binning, Bryan Q Spring, Patrick Hwu, Shari A Pilon-Thomas, Heiko Enderling
Rethinking the immunotherapy numbers game. Journal for immunotherapy of cancer 10 (7) (2022)
Hao Liu, Amy Weber, Jennifer Morse, Krithika Kodumudi, Ellen Scott, John Mullinax, Amod A Sarnaik, Shari A Pilon-Thomas
T cell mediated immunity after combination therapy with intralesional PV-10 and blockade of the PD-1/PD-L1 pathway in a murine melanoma model. PloS one 13 (4) (2018)